Global Peptide Synthesis Market Forecast to 2031: Size, Share, Trends, and Growth | GLP-1 Boom Lifts Demand for Peptide Synthesis

What happened: A new report forecasts the global peptide synthesis market will grow from $0.98 billion in 2026 to $1.54 billion by 2031, driven by GLP-1 drugs and expanding peptide pipelines. Key numbers: $0.98 billion in 2026 to $1.54 billion by 2031; CAGR of 9.5%; 30 companies profiled. Why it matters: Custom peptide synthesis services held the largest share in 2025 as pharma, biotech, CROs and CDMOs increasingly outsource complex peptide projects. Asia Pacific is forecast to record the highest CAGR. Market: -1.2% today ($685.82), +16.0% YTD, 0.5x vol — as of 15:47 UTC Verified: Q3_2026 (Oct 21) EPS $6.68 vs $6.40 est, +4.3% beat; next print ~Jan 20

A new report forecasts the global peptide synthesis market will grow from $0.98 billion in 2026 to $1.54 billion by 2031, driven by GLP-1 drugs and expanding peptide pipelines.

Custom peptide synthesis services held the largest share in 2025 as pharma, biotech, CROs and CDMOs increasingly outsource complex peptide projects. Asia Pacific is forecast to record the highest CAGR. Market: -1.2% today ($685.82), +16.0% YTD, 0.5x vol — as of 15:47 UTC Verified: Q3_2026 (Oct 21) EPS $6.68 vs $6.40 est, +4.3% beat; next print ~Jan 20